July 16, 2024
Computer System Validation Market
Ict

Computer System Validation Market Is Driven By Growing Regulatory Compliances

The computer system validation (CSV) involves ensuring that computer systems used in regulated processes meet specifications and perform correctly throughout their lifecycle. It is a multistage process used to ensure and document that a system conforms to user needs, and it is fitted for its intended uses. It includes user requirement specifications (URS), functional requirement specifications (FRS), system design specifications (SDS), and validation master plan (VMP). The increasing regulatory pressures and quality standards across industries such as pharmaceutical, biotechnology and medical devices are driving the adoption of CSV solutions globally. CSV solutions reduce compliance risks and ensures that critical systems perform consistently and accurately.

The global Computer System Validation Market is estimated to be valued at US$ 3.73 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Key Trends:

One of the major trends in the computer system validation market is the increasing adoption of continuous validation solutions. Continuous validation solutions allow companies to validate systems throughout the development and product lifecycles. It helps in identifying any issues and risks early. With continuous validation, companies can reduce cost and time of the validation process. It ensures ongoing compliance. Vendors are focusing on developing integrated continuous validation solutions with features such as automated test case generation, requirement traceability, risk analysis, and custom reporting. These solutions are gaining popularity globally as they help companies in streamlining validation operations and ensuring continued product quality. The growing requirement of agility and flexibility in validation is driving the demand for continuous validation solutions in the computer system validation market.

Porter’s Analysis

Threat of new entrants: Low barriers to entry due to limited technical expertise and capital investment requirements to enter the market. However, established players hold strong patent portfolios and regulatory approvals providing them significant advantages.

Bargaining power of buyers: Moderate bargaining power due to large number of buyers and presence of substitute products. Buyers can negotiate on price and exert pressure to reduce costs.

Bargaining power of suppliers: Low to moderate bargaining power of suppliers due to availability of alternative component suppliers and commoditization of raw materials. Suppliers rely on major players for bulk orders.

Threat of new substitutes: Low threat as computer system validation solutions cater to distinct quality control needs in pharmaceutical and life science industries. New substitutes would require considerable R&D and compliance with stringent regulations.

Competitive rivalry: High as market is dominated by few global players. Players compete based on portfolio expansion, pricing strategies, and offering technology enhancements and value-added services.

Key Takeaways

The Global Computer System Validation Market Demand is expected to witness high growth driven by increased compliance mandates for pharmaceutical drug development and manufacturing processes.

Regional analysis: North America dominates the market owing to stringent regulatory guidelines and widespread adoption among pharmaceutical companies in the region. Asia Pacific is expected to exhibit fastest growth on back of expanding biopharmaceutical industry, increasing R&D investments, and favorable government policies in major countries like China and India.

Key players operating in the computer system validation market are QIAGEN, Dicerna Pharmaceuticals Inc., Phio Pharmaceuticals Corp., Arcturus Therapeutics, Ionis Pharmaceuticals Inc., Sigma Aldrich (Merck KGaA), Benitec Biopharma Ltd., Silence Therapeutics PLC, SBI Biotech Co. Ltd., Alnylam Pharmaceuticals Inc., and Thermo Fisher Scientific Inc.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it